A previously study has confirmed the interaction between human 5-HT3A and antagonist Schisandrin C and discussed their relationship with irritable bowel syndrome (IBS) and the potential of Schisandrin C as a therapeutic agent [32]. This evidence concerns the gene HTR3A and irritable bowel syndrome.